Skip to content

Radiomics based on CT and MR imaging for preoperative predicting microvascular invasion of hepatocellular carcinoma: a clinical study

Radiomics based on CT and MR imaging for preoperative predicting microvascular invasion of hepatocellular carcinoma: a clinical study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046034
Enrollment
Unknown
Registered
2021-05-02
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. After evaluation by hepatobiliary surgery and imaging experts, the lesion is initially diagnosed as liver cancer and can be treated with surgery or liver transplantation; 2. Patients who underwent three-phase enhanced CT scan of the liver within 1 month before the operation; 3. Keep good image data, clinical data and pathological specimens for subsequent reassessment; 4. The pathology report gives a complete description of liver cancer.

Exclusion criteria

Exclusion criteria: Patients who have received TACE, chemoradiotherapy, radiofrequency ablation or other anti-tumor treatments before contrast-enhanced CT scan.

Design outcomes

Primary

MeasureTime frame
Microvascular invasion;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactHan Ping

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

cjr.hanping@vip.163.com+86 13707170023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026